Related Experiment Video
Updated: Oct 25, 2025

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
What telomeres teach us about MS
Annalise E Miner1, Jennifer S Graves1
1Department of Neurosciences, University of California, San Diego, USA.
Abstract:
While the precise mechanisms driving progressive forms of MS are not fully understood, patient age has clear impact on disease phenotype. The very young with MS have high relapse rates and virtually no progressive disease, whereas older patients tend to experience more rapid disability accumulation with few relapses. Defining a patient's biological age may offer more precision in determining the role of aging processes in MS phenotype and pathophysiology than just working with an individual's birthdate. The most well recognized measurement of an individual's "biological clock" is telomere length (TL). While TL may differ across tissue types in an individual, most cells TL correlate well with leukocyte TL (LTL), which is the most common biomarker used for aging. LTL has been associated with risk for aging related diseases and most recently with higher levels of disability and brain atrophy in people living with MS. LTL explains 15% of the overall association of chronological age with MS disability level. While LTL may be used just as a biomarker of overall somatic aging processes, triggering of the DNA damage response by telomere attrition leads to senescence pathways that are likely highly relevant to a chronic autoimmune disease. Considering reproductive aging factors, particularly ovarian aging in women, which correlates with LTL and oocyte telomere length, may complement measurements of somatic aging in understanding MS progression. The key to stopping non-relapse related progression in MS might lie in targeting pathways related to biological aging effects on the immune and nervous systems.
Insights
Biological age, measured by telomere length (TL), offers insight into multiple sclerosis (MS) progression. Leukocyte telomere length (LTL) correlates with disability and may help target aging pathways to slow MS advancement.
Area of Science:
- Neuroimmunology
- Aging Research
- Multiple Sclerosis Pathophysiology
Background:
- Patient age significantly influences multiple sclerosis (MS) disease phenotype, with younger patients experiencing relapses and older patients facing progressive disability.
- Chronological age is a limited predictor of MS progression; biological age may offer greater precision.
- Telomere length (TL), particularly leukocyte telomere length (LTL), is a recognized biomarker for biological aging and has been linked to aging-related diseases.
Purpose of the Study:
- To explore the role of biological aging, specifically telomere length, in the progression of multiple sclerosis (MS).
- To investigate whether leukocyte telomere length (LTL) can serve as a biomarker for MS disability and brain atrophy.
- To consider reproductive aging factors in conjunction with somatic aging for a comprehensive understanding of MS progression.
Main Methods:
- Review of existing literature on telomere length (TL) and its correlation with aging processes and diseases.
- Analysis of studies linking leukocyte telomere length (LTL) to disability levels and brain atrophy in individuals with MS.
- Consideration of the relationship between reproductive aging markers (e.g., ovarian aging) and somatic aging biomarkers (LTL).
Main Results:
- Leukocyte telomere length (LTL) is associated with increased disability and brain atrophy in people with MS.
- LTL accounts for 15% of the association between chronological age and MS disability.
- Telomere attrition can trigger DNA damage responses and senescence pathways, potentially relevant to chronic autoimmune diseases like MS.
Conclusions:
- Biological age, assessed via telomere length, provides a more nuanced understanding of MS progression than chronological age alone.
- Targeting pathways related to biological aging may be crucial for halting non-relapse-related progression in MS.
- Integrating reproductive aging factors with somatic aging markers may enhance the understanding of MS pathophysiology.
Related Concept Videos
Telomeres and Telomerase
Telomeres and Telomerase
Replicative Cell Senescence
Replication in Eukaryotes
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...
Replication in Eukaryotes
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

